We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.
BDSI

Delisted

BDSI was delisted on the 22nd of March, 2022.

Back to rankings

116 hedge funds and large institutions have $639M invested in BioDelivery Sciences International, Inc. in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more funds holding in top 10

Funds holding in top 10: 4 → 7 (+3)

58% more capital invested

Capital invested by funds: $403M → $639M (+$236M)

46% more call options, than puts

Call options by funds: $4.83M | Put options by funds: $3.31M

33% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 33

20% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 20

4% more funds holding

Funds holding: 112 → 116 (+4)

Holders
116
Holders Change
+4
Holders Change %
+3.57%
% of All Funds
3.37%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.2%
New
24
Increased
44
Reduced
33
Closed
20
Calls
$4.83M
Puts
$3.31M
Net Calls
+$1.51M
Net Calls Change
-$9.59M

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$35M
2
State Street
State Street
Massachusetts
+$21.4M
3
ICAP
Independence Capital Asset Partners
Colorado
+$10.9M
4
CCM
Cupps Capital Management
Illinois
+$7.84M
5
Wells Fargo
Wells Fargo
California
+$7.76M

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$19.4M
2
DM
Deerfield Management
New York
-$16M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$12.3M
4
PA
Perceptive Advisors
New York
-$5.72M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.59M
Name Holding Trade Value Shares
Change 		Change in
Stake
TDC
101
Thompson Davis & Co
Virginia
$118K +$43.5K +3,000 +77%
Legal & General Group
102
Legal & General Group
United Kingdom
$114K +$94.5K +6,513 New
Lazard Asset Management
103
Lazard Asset Management
New York
$104K +$88.8K +6,120 New
TRCT
104
Tower Research Capital (TRC)
New York
$97K +$82.5K +5,685 New
Citigroup
105
Citigroup
New York
$73K +$972 +67 +2%
LTFS
106
Ladenburg Thalmann Financial Services
Florida
$60K +$1.45K +100 +3%
EARNEST Partners
107
EARNEST Partners
Georgia
$48K – – –
BNP Paribas Financial Markets
108
BNP Paribas Financial Markets
France
$44.3K +$32.2K +2,219 +597%
Bank of Montreal
109
Bank of Montreal
Ontario, Canada
$27K -$13.5K -930 -37%
BlackRock
110
BlackRock
New York
$18K – – –
HF
111
Hoxton Financial
West Virginia
$7K – – –
Creative Planning
112
Creative Planning
Kansas
$5K – – –
Bessemer Group
113
Bessemer Group
New Jersey
$3K – – –
RFA
114
Reilly Financial Advisors
California
$2K – – –
CFA
115
Camarda Financial Advisors
Florida
$1K +$726 +50 New
Manulife (Manufacturers Life Insurance)
116
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$478 +$9.45K +651 +2%
DM
117
Deerfield Management
New York
– -$16M -1,328,300 Closed
Wellington Management Group
118
Wellington Management Group
Massachusetts
– -$4.59M -380,397 Closed
Two Sigma Investments
119
Two Sigma Investments
New York
– -$1.42M -117,241 Closed
HT
120
HAP Trading
New York
– -$1.21M -100,450 Closed
ARC
121
Absolute Return Capital
Massachusetts
– -$1.21M -99,798 Closed
Group One Trading
122
Group One Trading
Illinois
– -$943K -64,999 Closed
LOM
123
Loeb Offshore Management
New York
– -$594K -49,200 Closed
EMG
124
Ellington Management Group
Connecticut
– -$508K -42,100 Closed
PCM
125
Potomac Capital Management
New York
– -$377K -31,200 Closed
2 3 4
5
6

BDSI Hedge Fund Activity: Q3 2014 in Review

116 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q3 2014, worth a combined $639M — up 58% from $403M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new BDSI positions and 20 closed out — a net gain of 4 holders — while 44 added to existing stakes and 33 trimmed.

The largest buyer was Invesco, adding an estimated $35M. The largest seller was Broadfin Capital, cutting an estimated $19.4M.

  • 116 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q3 2014, up from 112 in Q2 2014.
  • Funds reported $639M of BioDelivery Sciences International, Inc. stock for Q3 2014, up 58% quarter-over-quarter.
  • 24 funds opened new BioDelivery Sciences International, Inc. positions in Q3 2014 and 20 closed out, a net change of +4 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q3 2014 was Invesco, an estimated $35M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q3 2014 was Broadfin Capital, an estimated $19.4M sold.

Based on aggregated 13F filings for Q3 2014.